Register before 19th June 2013,
and take advantage of our early-bird rates.

Molecular Neurodegeneration: Basic biology and disease pathways

Age-related neurodegenerative disorders currently affect millions of people worldwide and their prevalence is increasing at an alarming rate. Elucidating the basic biology and pathogenic mechanisms leading to neurodegeneration has therefore never been more urgent.

BioMed Central, in association with its journal Molecular Neurodegeneration, is pleased to host the 3^rd International Conference, Molecular Neurodegeneration: Basic biology and disease pathways.  This is the first time this leading conference will be based in Europe, having previously been held in Xiamen in 2009 and Shanghai in 2011.

The 2013 conference will see world-renowned experts present cutting-edge research that, in combination with poster presentations and short talks, will provide the latest updates on progress to uncover the molecular mechanisms underlying major devastating neurodegenerative diseases and promote discussion about new treatment strategies.

Molecular Neurodegeneration: Basic biology and disease pathways will take place at the Novotel Cannes Montfloury, Cannes, France from 10 -12 September 2013.

Organizing committee

Guojun Bu

Mayo Clinic, Jacksonville, Florida, USA

Robert Vassar

Northwestern University, Chicago, Illinois USA

Huaxi Xu

Sanford-Burnham Medical Research Institute, La Jolla, California, USA

Hui Zheng

Baylor College of Medicine, Houston, Texas, USA

Frédéric Checler

Université de Nice-Sophia-Antipolis, France

Henrietta M Nielsen

Mayo Clinic, Jacksonville, Florida, USA

Speakers

Guojun Bu

Mayo Clinic, Jacksonville, Florida, USA

Frédéric Checler

Université de Nice-Sophia-Antipolis , France

Don W Cleveland

Ludwig Institute & University of California, San Diego, USA

Bart De Strooper

VIB Center for the Biology of Disease, CHG and LR Institute for Neuroscience & Disease, Belgium

Todd E. Golde

University of Florida, USA

Christian Haass

Ludwig Maximilians University Munich and German Center for Neurodegenerative Diseases (DZNE), Germany

John Hardy

UCL Institute of Neurology, UK

Mikko Hiltunen

Institute of Clinical Medicine - Neurology, University of Eastern Finland, Finland

David M Holtzman

Washington University School of Medicine, USA

Mathias Jucker

University of Tübingen and German Center for Neurodegenerative Diseases (DZNE), Germany

Edward Koo

University of California, San Diego, USA

Dora Kovacs

Massachusetts General Hospital / Harvard Medical School, USA

Virginia M Lee

University of Pennsylvania School of Medicine, USA

Yueming Li

Memorial Sloan-Kettering Cancer Center, USA

Stefan Lichtenthaler

German Center for Neurodegenerative Diseases and Technische Universitaet Muenchen (DZNE), Germany

Eva Mandelkow

German Center for Neurodegenerative Diseases (DZNE), Germany

Eckhard Mandelkow

German Center for Neurodegenerative Diseases (DZNE), Germany

Jie Shen

Harvard Medical School, USA

Sangram S Sisodia

The University of Chicago, USA

Peter St George-Hyslop

Cambridge Institute for Medical Research, University of Cambridge, UK & University of Toronto, Canada

Rudolph Tanzi

Harvard Medical School/Massachusetts General Hospital, USA

John Q Trojanowski

University of Pennsylvania School of Medicine, USA

Robert Vassar

Northwestern University,Chicago, Illinois , USA

Huaxi Xu

Sanford-Burnham Medical Research Institute, La Jolla, California, USA

Hui Zheng

Baylor College of Medicine, Houston, Texas, USA

BioMed Central

BioMed Central is an STM (Science, Technology and Medicine) publisher that has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.